Congress Moves to Open the Door to Psychedelic Therapy for Veterans
A bipartisan group of military veterans serving in the U.S. Senate introduced legislation that could fundamentally change how the VA treats mental health. Senate Bill 4220, the Veterans Health Administration Novel Therapeutics Preparedness Act, would build the internal infrastructure the VA needs to deploy psychedelic therapies once the FDA approves them. Advocates call it the first real step toward closing a treatment gap that has cost veterans their lives.
Looking for treatment? Find ketamine clinics closest to you as well as other psychedelic therapies in your area.
| Key Takeaway | Detail |
|---|---|
| Bill name | Veterans Health Administration Novel Therapeutics Preparedness Act (SB 4220) |
| Lead sponsor | Sen. Tim Sheehy (R-MT), a Navy SEAL veteran |
| Co-sponsors | Sens. Ruben Gallego (D-AZ), Tammy Duckworth (D-IL), John Boozman (R-AR) |
| Core action | Creates an Office of Novel Therapeutics within the VA |
| Target conditions | PTSD, depression, substance use disorders, TBI, chronic pain |
| Advocacy assessment | Called “the first major step in the right direction” |
What the Bill Would Actually Do
Sen. Tim Sheehy introduced the legislation on March 27. It creates a dedicated Office of Novel Therapeutics inside the Veterans Health Administration. That office would develop national clinical standards and safety protocols. It would train clinicians and peer support specialists on emerging therapies. It would also designate Centers of Excellence at select VA medical facilities to lead research and share best practices.
The bill requires annual reporting to Congress. It mandates coordination with the FDA, DEA, HHS, CMS, and DOD to clear regulatory and reimbursement pathways. The goal is readiness before approvals arrive — not a scramble after them.
Veterans Groups Are Paying Attention
Major veterans organizations expressed support. Dr. Kyleanne Hunter, CEO of Iraq and Afghanistan Veterans of America, said the health care system has not kept pace with the science. Jim Marszalek of Disabled American Veterans put it plainly: the infrastructure needs to be built before these therapies arrive, not after.
The Stigma Still Exists But It Is Shifting
Juliana Mercer, executive director of Healing Breakthrough and a Marine Corps veteran, has met with more than 550 congressional offices over the past four years. Roughly 90 percent expressed support for expanding access to these therapies. The remaining resistance, she says, comes down to stigma — particularly from those who see psychedelics only as a Schedule I substance and stop there.
That framing is changing. For veterans who have exhausted conventional treatments, the progress happening in Congress reflects something they have been pushing for a long time.
Provider that may work for you: Oakton Primary Care
Provider that may work for you: Optimal Health Miami
Provider that may work for you: JourneyŌM ‘ San Francisco, California
Provider that may work for you: Total Performance Medical Center
Provider that may work for you: InnerTrek Facilitator Training ‘ Portland, Oregon
Provider that may work for you: Tikkun Urban Baka Jerusalem ‘ Baka Jerusalem, Israel
Provider that may work for you: BIO Medspa
